valine and Glomerulonephritis, Membranoproliferative

valine has been researched along with Glomerulonephritis, Membranoproliferative in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, T; Murakami, R; Nakamura, M; Nakamura, N; Narita, I; Shimada, M; Tomita, H; Yamabe, H1
Bakr, MA; El Maghrabi, HM; Elmowafy, AY; Elwasif, SM; Zahab, MA1
Arakawa, M; Murata, Y; Rikimaru, Y; Sasaki, Y1
Akdag, I; Filiz, G; Gullulu, M; Kahvecioglu, S; Savci, V1
Ikee, R; Kobayashi, S; Maesato, K; Mano, T; Moriya, H; Ohtake, T; Oka, M1

Reviews

1 review(s) available for valine and Glomerulonephritis, Membranoproliferative

ArticleYear
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
    BMC nephrology, 2017, Mar-29, Volume: 18, Issue:1

    Topics: Aged; Antiviral Agents; Carbamates; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Imidazoles; Isoquinolines; Pyrrolidines; Sulfonamides; Treatment Outcome; Valine

2017

Other Studies

4 other study(ies) available for valine and Glomerulonephritis, Membranoproliferative

ArticleYear
Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
    Iranian journal of kidney diseases, 2018, Volume: 12, Issue:6

    Topics: Antiviral Agents; Carbamates; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Humans; Imidazoles; Middle Aged; Pyrrolidines; Sofosbuvir; Treatment Outcome; Valine

2018
Drug-induced isolated visceral angioneurotic edema.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:9

    Topics: Adult; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Humans; Lisinopril; Renal Dialysis; Tetrazoles; Valine; Valsartan

2005
Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well.
    Renal failure, 2006, Volume: 28, Issue:6

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cell Proliferation; Disease Models, Animal; Diuretics; Fibrosis; Glomerulonephritis, Membranoproliferative; Ki-67 Antigen; Kidney; Mineralocorticoid Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2006
Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:3

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biopsy; Creatinine; Female; Fibrosis; Glomerulonephritis, Membranoproliferative; Humans; Immunoglobulin A; Kidney Glomerulus; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Retrospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilation

2008